(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of PRKCH protein CTD PMID:15058486 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:735345 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PRKCH mRNA CTD PMID:22079256 1,2-dichloroethane affects expression ISO RGD:732913 6480464 ethylene dichloride affects the expression of PRKCH mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:732913 6480464 1, 2-Dimethylhydrazine results in increased expression of PRKCH mRNA CTD PMID:22206623 1-nitropyrene increases expression ISO RGD:735345 6480464 1-nitropyrene results in increased expression of PRKCH mRNA CTD PMID:19041380 17alpha-ethynylestradiol multiple interactions ISO RGD:732913 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRKCH mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:735345 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of PRKCH mRNA CTD PMID:30165855 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:735345 6480464 Dihydrotestosterone results in increased expression of PRKCH mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732913 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRKCH mRNA, [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PRKCH mRNA CTD PMID:17942748 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKCH mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735345 6480464 Tetrachlorodibenzodioxin results in increased expression of PRKCH mRNA CTD PMID:23152189 2-acetamidofluorene multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of PRKCH mRNA, [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PRKCH mRNA CTD PMID:14656948 , PMID:16158176 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of PRKCH mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression ISO RGD:735345 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PRKCH mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol decreases methylation ISO RGD:735345 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of PRKCH gene CTD PMID:31601247 4,4'-sulfonyldiphenol multiple interactions ISO RGD:735345 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of PRKCH gene CTD PMID:31601247 4,4'-sulfonyldiphenol increases expression ISO RGD:732913 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PRKCH mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:732913 6480464 Fenretinide results in increased expression of PRKCH mRNA CTD PMID:28973697 acetamide increases expression EXP 6480464 acetamide results in increased expression of PRKCH mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:732913 6480464 Acrylamide results in increased expression of PRKCH mRNA CTD PMID:30807115 aflatoxin B1 increases methylation ISO RGD:735345 6480464 Aflatoxin B1 results in increased methylation of PRKCH intron CTD PMID:30157460 aflatoxin B1 decreases methylation ISO RGD:735345 6480464 Aflatoxin B1 results in decreased methylation of PRKCH promoter CTD PMID:30157460 Aflatoxin B2 alpha decreases methylation ISO RGD:735345 6480464 aflatoxin B2 results in decreased methylation of PRKCH promoter CTD PMID:30157460 aldehydo-D-glucose decreases expression ISO RGD:732913 6480464 Glucose results in decreased expression of PRKCH mRNA CTD PMID:17178593 all-trans-retinoic acid increases expression ISO RGD:735345 6480464 Tretinoin results in increased expression of PRKCH mRNA CTD PMID:17431108 amitrole increases expression EXP 6480464 Amitrole results in increased expression of PRKCH mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PRKCH mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of PRKCH mRNA CTD PMID:16101753 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of PRKCH mRNA CTD PMID:30779732 aristolochic acid A increases expression ISO RGD:735345 6480464 aristolochic acid I results in increased expression of PRKCH mRNA CTD PMID:33212167 arsenite(3-) increases expression ISO RGD:732913 6480464 arsenite results in increased expression of PRKCH mRNA CTD PMID:33053406 arsenous acid increases expression ISO RGD:735345 6480464 Arsenic Trioxide results in increased expression of PRKCH mRNA CTD PMID:20458559 atrazine decreases expression ISO RGD:735345 6480464 Atrazine results in decreased expression of PRKCH mRNA CTD PMID:22378314 benzene increases expression ISO RGD:735345 6480464 Benzene results in increased expression of PRKCH mRNA CTD PMID:20036648 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of PRKCH mRNA CTD PMID:21839799 benzo[a]pyrene affects methylation ISO RGD:735345 6480464 Benzo(a)pyrene affects the methylation of PRKCH promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:735345 6480464 Benzo(a)pyrene results in decreased methylation of PRKCH 5' UTR, Benzo(a)pyrene results in decreased methylation of PRKCH exon CTD PMID:27901495 benzo[e]pyrene decreases methylation ISO RGD:735345 6480464 benzo(e)pyrene results in decreased methylation of PRKCH promoter CTD PMID:30157460 bis(2-ethylhexyl) phthalate increases expression ISO RGD:735345 6480464 Diethylhexyl Phthalate results in increased expression of PRKCH mRNA CTD PMID:31163220 bisphenol A increases methylation ISO RGD:735345 6480464 bisphenol A results in increased methylation of PRKCH gene CTD PMID:22576693 bisphenol A increases expression ISO RGD:732913 6480464 bisphenol A results in increased expression of PRKCH mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO RGD:735345 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PRKCH gene CTD PMID:31601247 bisphenol A decreases methylation ISO RGD:735345 6480464 bisphenol A results in decreased methylation of PRKCH gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:735345 6480464 bisphenol A results in decreased expression of PRKCH mRNA CTD PMID:22576693 , PMID:27685785 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PRKCH mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:732913 6480464 bisphenol A results in decreased expression of PRKCH mRNA CTD PMID:26063408 , PMID:34585602 bisphenol F increases expression ISO RGD:732913 6480464 bisphenol F results in increased expression of PRKCH mRNA CTD PMID:30951980 captan decreases expression ISO RGD:732913 6480464 Captan results in decreased expression of PRKCH mRNA CTD PMID:31558096 carbon nanotube increases expression ISO RGD:732913 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:735345 6480464 CGP 52608 promotes the reaction [RORA protein binds to PRKCH gene] CTD PMID:28238834 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of PRKCH mRNA CTD PMID:17452286 , PMID:19368821 chlorpyrifos increases expression ISO RGD:732913 6480464 Chlorpyrifos results in increased expression of PRKCH mRNA CTD PMID:37019170 chromium(6+) affects expression ISO RGD:732913 6480464 chromium hexavalent ion affects the expression of PRKCH mRNA CTD PMID:28472532 clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of PRKCH mRNA CTD PMID:30047161 cobalt dichloride decreases expression ISO RGD:735345 6480464 cobaltous chloride results in decreased expression of PRKCH mRNA CTD PMID:19320972 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of PRKCH mRNA CTD PMID:24386269 coumarin decreases phosphorylation ISO RGD:735345 6480464 coumarin results in decreased phosphorylation of PRKCH protein CTD PMID:35688186 coumestrol decreases expression ISO RGD:735345 6480464 Coumestrol results in decreased expression of PRKCH mRNA CTD PMID:19167446 curcumin multiple interactions ISO RGD:735345 6480464 Curcumin inhibits the reaction [PRKCH protein results in increased expression of IVL mRNA] CTD PMID:17148446 D-glucose decreases expression ISO RGD:732913 6480464 Glucose results in decreased expression of PRKCH mRNA CTD PMID:17178593 diarsenic trioxide increases expression ISO RGD:735345 6480464 Arsenic Trioxide results in increased expression of PRKCH mRNA CTD PMID:20458559 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of PRKCH mRNA CTD PMID:17452286 dorsomorphin multiple interactions ISO RGD:735345 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:735345 6480464 Doxorubicin results in decreased expression of PRKCH mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of PRKCH mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:735345 6480464 entinostat results in increased expression of PRKCH mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:735345 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCH mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:732913 6480464 epoxiconazole results in decreased expression of PRKCH mRNA CTD PMID:35436446 ethanol affects expression ISO RGD:732913 6480464 Ethanol affects the expression of PRKCH mRNA CTD PMID:30319688 folpet decreases expression ISO RGD:732913 6480464 folpet results in decreased expression of PRKCH mRNA CTD PMID:31558096 fulvestrant multiple interactions ISO RGD:735345 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of PRKCH gene, [bisphenol A co-treated with Fulvestrant] results in increased methylation of PRKCH gene CTD PMID:31601247 gallic acid decreases expression ISO RGD:735345 6480464 Gallic Acid results in decreased expression of PRKCH mRNA CTD PMID:34408198 gamma-hexachlorocyclohexane affects expression EXP 6480464 Hexachlorocyclohexane affects the expression of PRKCH mRNA CTD PMID:22001173 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PRKCH mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PRKCH mRNA CTD PMID:33387578 glucose decreases expression ISO RGD:732913 6480464 Glucose results in decreased expression of PRKCH mRNA CTD PMID:17178593 hydrogen cyanide decreases expression ISO RGD:732913 6480464 Hydrogen Cyanide results in decreased expression of PRKCH mRNA CTD PMID:33914522 hydrogen peroxide affects expression ISO RGD:735345 6480464 Hydrogen Peroxide affects the expression of PRKCH mRNA CTD PMID:20044591 indometacin increases expression ISO RGD:735345 6480464 Indomethacin results in increased expression of PRKCH protein CTD PMID:10702201 lead diacetate increases expression ISO RGD:732913 6480464 lead acetate results in increased expression of PRKCH mRNA CTD PMID:20542052 lipopolysaccharide decreases expression ISO RGD:732913 6480464 Lipopolysaccharides results in decreased expression of PRKCH mRNA CTD PMID:26582142 mercury dibromide increases expression ISO RGD:735345 6480464 mercuric bromide results in increased expression of PRKCH mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:735345 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCH mRNA CTD PMID:27188386 methapyrilene decreases methylation ISO RGD:735345 6480464 Methapyrilene results in decreased methylation of PRKCH promoter CTD PMID:30157460 methimazole increases expression EXP 6480464 Methimazole results in increased expression of PRKCH mRNA CTD PMID:30047161 methoxyacetic acid affects expression EXP 6480464 methoxyacetic acid affects the expression of PRKCH mRNA CTD PMID:20864626 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of PRKCH gene CTD PMID:35440735 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of PRKCH gene CTD PMID:33148267 N-nitrosodiethylamine multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of PRKCH mRNA, [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PRKCH mRNA CTD PMID:14656948 , PMID:16158176 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of PRKCH mRNA CTD PMID:17032414 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of PRKCH mRNA CTD PMID:23665939 ozone multiple interactions ISO RGD:732913 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PRKCH mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO RGD:735345 6480464 p-Chloromercuribenzoic Acid results in increased expression of PRKCH mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:735345 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCH mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:735345 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCH mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:735345 6480464 panobinostat results in increased expression of PRKCH mRNA CTD PMID:26272509 paracetamol multiple interactions ISO RGD:735345 6480464 [Dietary Carbohydrates co-treated with Acetaminophen] results in decreased expression of PRKCH mRNA CTD PMID:17093179 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PRKCH mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:732913 6480464 Acetaminophen affects the expression of PRKCH mRNA CTD PMID:17562736 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of PRKCH gene CTD PMID:33148267 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of PRKCH mRNA CTD PMID:19162173 phenylmercury acetate increases expression ISO RGD:735345 6480464 Phenylmercuric Acetate results in increased expression of PRKCH mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:735345 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCH mRNA CTD PMID:27188386 phlorizin increases expression ISO RGD:732913 6480464 Phlorhizin results in increased expression of PRKCH mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate increases activity ISO RGD:735345 6480464 Tetradecanoylphorbol Acetate results in increased activity of PRKCH protein CTD PMID:16832347 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:735345 6480464 [Tetradecanoylphorbol Acetate results in increased activity of PRKCH protein] inhibits the reaction [Sirolimus results in decreased phosphorylation of RPS6 protein] CTD PMID:16832347 potassium chromate decreases expression ISO RGD:735345 6480464 potassium chromate(VI) results in decreased expression of PRKCH mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:735345 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PRKCH mRNA CTD PMID:22079256 potassium cyanide increases expression ISO RGD:732913 6480464 Potassium Cyanide results in increased expression of PRKCH mRNA CTD PMID:33914522 propanal increases expression ISO RGD:735345 6480464 propionaldehyde results in increased expression of PRKCH mRNA CTD PMID:26079696 quercetin decreases expression ISO RGD:732913 6480464 Quercetin results in decreased expression of PRKCH mRNA CTD PMID:26076811 SB 431542 multiple interactions ISO RGD:735345 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sirolimus decreases response to substance ISO RGD:735345 6480464 PRKCH results in decreased susceptibility to Sirolimus CTD PMID:16832347 sirolimus multiple interactions ISO RGD:735345 6480464 [Tetradecanoylphorbol Acetate results in increased activity of PRKCH protein] inhibits the reaction [Sirolimus results in decreased phosphorylation of RPS6 protein] CTD PMID:16832347 sodium dichromate decreases expression ISO RGD:732913 6480464 sodium bichromate results in decreased expression of PRKCH mRNA CTD PMID:31558096 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of PRKCH mRNA CTD PMID:30047161 sunitinib increases expression ISO RGD:735345 6480464 Sunitinib results in increased expression of PRKCH mRNA CTD PMID:31533062 tert-butyl hydroperoxide increases expression ISO RGD:735345 6480464 tert-Butylhydroperoxide results in increased expression of PRKCH mRNA CTD PMID:15336504 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of PRKCH mRNA CTD PMID:12734012 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PRKCH mRNA CTD PMID:17032414 thapsigargin decreases expression ISO RGD:735345 6480464 Thapsigargin results in decreased expression of PRKCH mRNA CTD PMID:22378314 , PMID:29453283 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PRKCH mRNA CTD PMID:34492290 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of PRKCH gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:735345 6480464 trichostatin A results in increased expression of PRKCH mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:735345 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCH mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:735345 6480464 Triclosan results in decreased expression of PRKCH mRNA CTD PMID:30510588 tunicamycin decreases expression ISO RGD:735345 6480464 Tunicamycin results in decreased expression of PRKCH mRNA CTD PMID:22378314 , PMID:29453283 valproic acid affects expression ISO RGD:735345 6480464 Valproic Acid affects the expression of PRKCH mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:735345 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCH mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:735345 6480464 Valproic Acid results in increased expression of PRKCH mRNA CTD PMID:23179753 more ... vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PRKCH mRNA CTD PMID:19015723 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of PRKCH gene CTD PMID:31682807 vorinostat multiple interactions ISO RGD:735345 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCH mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:735345 6480464 vorinostat results in increased expression of PRKCH mRNA CTD PMID:26272509
